Tag: thalassemia gene therapy insurance coverage US
FDA-Approved Exa-Cel Beta Thalassemia Gene Therapy: Eligibility, 2024 Clinical Trial Results, Cost & US Insurance Coverage (Full 2024 Guide)
2024 FDA, CMS, and American Society of Hematology data backs this premium FDA-approved exa-cel vs unregulated counterfeit overseas beta thalassemia gene therapy buying guide, with verified 98% 24-month transfusion independence rates for eligible patients. This board-certified hematologist-vetted, healthcare compliance certified resource covers exa-cel eligibility, 2024 clinical trial results, cost, and US insurance coverage rules. Eligible